Avient (AVNT) Q2 2024: Organic Sales Rise 5% as Volume Growth Returns to Core Segments
Avient’s second quarter marks a clear inflection point, with organic sales growth resuming after seven stagnant quarters and margin expansion driven by volume gains and disciplined cost control. Broad-based demand recovery, restocking, and share wins underpin the improved outlook, while management signals a pivot toward innovation and operational scale ahead of its December Investor Day. With inflationary pressures returning in the second half and mix still in flux, the next phase will test Avient’s ability to sustain profitable growth through both market and self-driven levers.
Summary
- Volume-Driven Recovery: Organic sales growth returned, fueled by restocking and share gains in core end markets.
- Margin Expansion: Operational discipline and raw material tailwinds lifted margins, but inflation is set to return.
- Strategic Reset Ahead: Management is consolidating R&D and go-to-market, with a new plan to be unveiled in December.
Business Overview
Avient is a specialty materials and polymer solutions provider, generating revenue through two main segments: Color, Additives & Inks (CAI), which delivers colorants and performance additives for packaging, consumer, and industrial end markets, and Specialty Engineered Materials (SEM), focused on high-performance polymers for healthcare, building and construction, energy, and defense. The company’s business model is anchored in value-added materials innovation, serving global OEMs and converters, and is exposed to cyclical trends in manufacturing, packaging, and infrastructure spending.
Performance Analysis
Avient delivered a decisive turnaround in Q2 2024, posting 5% organic sales growth after seven quarters of stagnation, with both CAI and SEM segments contributing. The rebound was broad-based: packaging and consumer end markets grew 8% and 10% respectively, driven by restocking and share gains, while healthcare sales rose 10% as destocking abated and new applications in drug delivery accelerated. Building and construction and defense also saw above-market growth, with the latter benefiting from NATO-related programs and law enforcement demand.
Margins expanded by 100 basis points to 16.9%, reflecting strong cost control, raw material deflation, and favorable mix. Adjusted EPS grew 21% YoY, supported by volume leverage and lower interest expense from prior debt actions. Regional performance was robust in the Americas—Latin America sales surged 19% on packaging demand, and U.S./Canada grew 5%—while EMEA and Asia posted modest gains despite ongoing macro headwinds. However, telecom and energy remained challenged, down double digits, though both are expected to improve in the second half as restocking and infrastructure projects ramp up.
- Healthcare Inflection: Restocking ended, with double-digit growth in devices and drug delivery applications, and share gains in both CAI and SEM.
- Operational Leverage: Volume gains, cost discipline, and raw material deflation drove margin expansion, but input inflation is set to return in H2.
- Regional Divergence: Latin America outperformed on packaging, while EMEA and Asia remain more exposed to macro and industrial volatility.
Growth was primarily volume-driven, not price/mix, and management expects this dynamic to persist into the second half, with innovation and new applications set to play a larger role in 2025.
Executive Commentary
"One of our main areas of focus is to deliver organic top-line growth with margin expansion, and this quarter we achieved both. The organic revenue growth was broad-based across all geographies and in both of our business segments... Both segments benefited from gaining share, winning new product specifications, and inventory restocking in certain end markets."
Dr. Ashish Kanpur, President and Chief Executive Officer
"Margin expansion was helped by strong operational and cost-controlled discipline by our teams, as well as raw material deflation... We expect to build on this growth in the U.S. and Canada in the second half of the year, as we are also seeing increasing momentum from composite applications that replace conventional building materials and improving trends in the U.S. telecom and energy end markets."
Jamie Beggs, Senior Vice President and Chief Financial Officer
Strategic Positioning
1. Volume-Led Growth and Share Gains
Management emphasized that Q2’s growth was almost entirely volume-driven, not price/mix. Share gains in traditional engineered materials and new applications in building, construction, and healthcare were key contributors. Restocking and underlying demand recovery provided a strong platform, but Avient’s ability to win new business and specifications, especially in healthcare and defense, stands out as a differentiator.
2. Innovation and R&D Realignment
Avient is consolidating its R&D and technology resources, shifting from a fragmented legacy structure toward a more centralized, scalable innovation engine. The upcoming hire of a CTO and a new marketing lead signals a push to accelerate new product development and commercialize technologies in high-growth verticals like electrification, AI-driven infrastructure, and sustainable composites.
3. Margin Expansion Amid Cost Shifts
Q2 margin gains were supported by raw material deflation and cost discipline, but management flagged that $35 million in first-half cost tailwinds will reverse as inflation returns in H2, especially in hydrocarbons, pigments, and additives. The ability to hold net price and expand margins as input costs rise will be a key test for the back half.
4. Regional Strategy and Nearshoring
Latin America emerged as a growth engine, benefiting from nearshoring trends and resilient demand in packaging and consumer. Avient’s local presence and ability to serve global OEMs seeking supply chain resilience positions it well for continued share gains as trade flows shift. EMEA and Asia remain more exposed to macro volatility but are showing early signs of recovery in packaging and consumer.
5. Strategic Plan and Leadership Focus
CEO Kanpur highlighted three pillars for the upcoming strategic plan: organic top-line growth with margin expansion, amplified innovation, and leadership/talent development. The December 4th Investor Day will be a key catalyst for clarity on long-term earnings power and capital allocation priorities.
Key Considerations
Avient’s Q2 signals a new phase of growth, but the sustainability of volume-driven gains and the transition to innovation-led expansion will define the next leg. Investors should weigh the following:
- Volume Momentum: Continued volume growth in H2 is expected, but will depend on restocking trends, new application wins, and macro stability in key end markets.
- Input Cost Headwinds: Raw material inflation is set to return, with $5-$10 million headwind forecast in H2. Margin management will be critical.
- Healthcare and Defense Upside: Double-digit growth in these segments is being driven by innovation and new partnerships, supporting above-market performance.
- R&D and Go-to-Market Realignment: Consolidation of innovation resources and new leadership hires are aimed at building a scalable product pipeline for future years.
- Strategic Plan Reveal: December’s Investor Day is a near-term catalyst for clarity on long-term growth and capital deployment.
Risks
Macro volatility remains a significant risk, especially in EMEA and Asia where industrial demand and consumer confidence are fragile. Raw material inflation could pressure margins if pricing discipline slips. Execution risk around R&D consolidation and the ability to commercialize new innovations at scale may introduce transition friction. End market cyclicality, especially in telecom and energy, adds further uncertainty to the growth outlook.
Forward Outlook
For Q3 2024, Avient guided to:
- Adjusted EPS of $0.62, up 9% YoY
- Continued organic sales growth in the mid-single digits
For full-year 2024, management raised guidance:
- Adjusted EBITDA of $515M to $540M
- Adjusted EPS of $2.55 to $2.70, representing 8% to 14% YoY growth
Management highlighted several factors that will shape H2:
- Raw material inflation returning, especially in hydrocarbons and pigments
- Volume growth expected to remain the primary driver, with price/mix less material
Takeaways
Avient’s Q2 marks a shift to organic growth and sets the stage for a more innovation-driven future, but the sustainability of margin gains and execution on strategic priorities will be closely watched.
- Volume Growth Returns: Restocking, share gains, and new applications drove broad-based recovery, with healthcare and defense leading upside.
- Margin and Cost Discipline: Margin expansion was achieved through operational rigor and favorable input costs, but inflation will test resilience in H2.
- Innovation and Strategy Reset: The December Investor Day and new leadership hires are pivotal for Avient’s long-term differentiation and growth trajectory.
Conclusion
Avient delivered a clear pivot to growth and margin expansion in Q2, supported by volume gains and operational execution. The transition to a more innovation-led model is underway, with the upcoming strategic plan set to define the company’s next growth phase. Sustaining momentum through inflation and macro volatility remains the critical challenge for the balance of 2024.
Industry Read-Through
Avient’s volume-led rebound and restocking trends signal a broader stabilization in downstream manufacturing and packaging demand, especially in North America and Latin America. The company’s ability to extract margin in both inflationary and deflationary raw material environments offers a template for specialty materials peers. Healthcare and defense end markets are emerging as secular growth drivers, while regional strategies around nearshoring and supply chain resilience are gaining traction. The renewed focus on centralized R&D and commercialization underscores a sector-wide shift toward innovation scale and operational agility as macro volatility persists. Investors across the chemicals and materials sector should watch for similar volume-driven recoveries and strategic pivots toward high-value applications.